Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
27.9M
-
Shares change
-
+251K
-
Total reported value, excl. options
-
$2.64B
-
Value change
-
-$37M
-
Put/Call ratio
-
1.68
-
Number of buys
-
95
-
Number of sells
-
-63
-
Price
-
$94.30
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q1 2015
183 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q1 2015.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.9M shares
of 58.6M outstanding shares and own 47.65% of the company stock.
Largest 10 shareholders include FMR LLC (5.58M shares), WELLINGTON MANAGEMENT GROUP LLP (3.25M shares), Capital World Investors (3.16M shares), Flagship Ventures 2007 General Partner LLC (1.93M shares), BB BIOTECH AG (1.85M shares), VANGUARD GROUP INC (1.59M shares), Capital International Investors (1.06M shares), BlackRock Fund Advisors (841K shares), CAPITAL GUARDIAN TRUST CO (759K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (660K shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.